Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Capricor Therapeutics (CAPR) over the last 16 years, with Dec 2024 value amounting to -$41.2 million.

  • Capricor Therapeutics' Free Cash Flow fell 69.46% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$62.8 million, marking a year-over-year decrease of 65.05%. This contributed to the annual value of -$41.2 million for FY2024, which is 52.97% down from last year.
  • As of FY2024, Capricor Therapeutics' Free Cash Flow stood at -$41.2 million, which was down 52.97% from -$26.9 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Free Cash Flow registered a high of $2.9 million during FY2022, and its lowest value of -$41.2 million during FY2024.
  • In the last 3 years, Capricor Therapeutics' Free Cash Flow had a median value of -$26.9 million in 2023 and averaged -$21.7 million.
  • Per our database at Business Quant, Capricor Therapeutics' Free Cash Flow spiked by 116.20% in 2022 and then plummeted by 1,022.65% in 2023.
  • Yearly analysis of 5 years shows Capricor Therapeutics' Free Cash Flow stood at -$10.6 million in 2020, then crashed by 69.83% to -$18.0 million in 2021, then skyrocketed by 116.20% to $2.9 million in 2022, then crashed by 1,022.65% to -$26.9 million in 2023, then tumbled by 52.97% to -$41.2 million in 2024.